Neuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study

Authors

  • Homa Rassouli
  • Maliheh Nobakht
  • Mehrdad Roghani
  • Mohammad Taghi Joghataie
Abstract:

  Abstract   Introduction: Neurodegeneration change is one of the hallmark symptoms of which Alzheimer’s disease (AD) can be modeled by β-amyloid injection into specific regions of brain. (-)-Epigallocatechin-3-gallate (EGCG) is a potent antioxidant agent that its role against oxidative stress and inflammation has been shown in prior studies. In the present study, we have wanted to determine whether EGCG administration protects against β-amyloid induced cell damages in rats .   Methods: Animals (male Wistar rats) divided into four groups: sham operated (SH), EGCG-pretreated sham operated (SH + EGCG), untreated lesion (L), and EGCG-pretreated lesion (L + EGCG). Animals in L, L + EGCG, and SH + EGCG groups received sterile saline or saline plus EGCG (10 mg/kg) intraperitoneally one day pre-surgery and every other day for three weeks. The lesion was induced one day after EGCG treatment by injection of water or water containing 2 nmol/µl of β-amyloid (1-40) into the hippocampal fissure. We evaluat ed the morphological changes of hippocampus specially CA3 region by nissl staining after three weeks of surgery .   Results: We found that β-amyloid (1-40) injection into hippocampus causes cell death of CA3 region in L group in comparison with SH group which also occurs in the Alzheimer’s disease. On the other hand, treatment with EGCG can improve the validity of these cells in hippocampus .   Discussion: We concluded that EGCG could be effective in protection against pathogenesis of Alzheimer’s disease .  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

neuroprotective effects of epigallocatechin-3-gallate in an experimental model of alzheimer’s disease in rat: a histological study

abstract   introduction: neurodegeneration change is one of the hallmark symptoms of which alzheimer’s disease (ad) can be modeled by β-amyloid injection into specific regions of brain. (-)-epigallocatechin-3-gallate (egcg) is a potent antioxidant agent that its role against oxidative stress and inflammation has been shown in prior studies. in the present study, we have wanted to determine whet...

full text

The Beneficial Effect of (-)-Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s disease in Rat: a Behavioral Analysis

Progressive cognitive decline is one of the hallmark symptoms of Alzheimer’s disease (AD) which can be modeled by β-amyloid injection into specific regions of brain. Since epigallocatechin-3-gallate (EGCG) is a potent antioxidant agent which its role against oxidative stress and inflammation has been shown in prior studies, we tried to determine whether EGCG administration protects against β-am...

full text

the beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of alzheimer’s disease in rat: a behavioral analysis

progressive cognitive decline is one of the hallmark symptoms of alzheimer’s disease (ad) which can be modeled by β-amyloid injection into specific regions of brain. since epigallocatechin-3-gallate (egcg) is a potent antioxidant agent which its role against oxidative stress and inflammation has been shown in prior studies, we tried to determine whether egcg administration protects against β-am...

full text

The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.

BACKGROUND Progressive cognitive decline is one of the hallmark symptoms of Alzheimer's disease (AD) which can be modeled by beta-amyloid injection into specific regions of brain. Since epigallocatechin-3-gallate (EGCG) is a potent antioxidant agent which its role against oxidative stress and inflammation has been shown in prior studies, we tried to determine whether EGCG administration protect...

full text

The Effect of Epigallocatechin gallate on Morphine Induced Working Memory Defects in Rats: An Experimental Study

Background and Objectives: Chronic morphine use leads to structural changes in the brain. Some studies have shown the antioxidant and neuroprotective effects of Epigallocatechin gallate (EGCG) as a main polyphenol of green tea. Therefore, the aim of this study was to investigate the effect of EGCG on working memory in morphine-treated rats. Materials and Methods: In this experimental study, 32...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 1

pages  7- 12

publication date 2009-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023